Article Text

FRI0058 Expression of specific pathways in the inflamed synovial membrane of osteoarthritis patient: Identification of new potential key intermediates
  1. C. Lambert1,
  2. J.-E. Dubuc2,
  3. B. Hennuy3,
  4. E. Montell4,
  5. J. Vergés4,
  6. Y. Henrotin5
  1. 1Bone and Cartilage Research Unit, University of Liège, Liège
  2. 2Orthopaedic Department, Cliniques Universitaires St. Luc, Brussels
  3. 3GIGA Genomics Core Facility, University of Liège, Liège, Belgium
  4. 4Basic Research Unit. Scientific Medical Department, Bioibérica, Barcelona
  5. 5Bone and Cartilage Research Unit, University of Liège, Liège, Spain


Background Synovitis is a key factor in osteoarthritis (OA) pathophysiology.

Objectives We investigated the gene expression profiles of synovial cells from two different areas and identified differentially regulated pathways, using an original methodology comparing normal/reactive (N/R) and inflammatory (I) synovial membranes zones.

Methods Synovial cells were isolated from OA synovial specimens obtained from 12 patients undergoing knee replacement. The inflammatory status of the synovial membrane was characterized according to a macroscopic criteria. The synovial membrane was dissected and biopsies from N/R and I areas cultured separately. Total RNA was extracted using the RNeasy Mini Kit. Gene expression profiling between N/R and I areas was performed using Illumina’s multi-sample format Human HT-12 BeadChip. Differential analysis was performed with the BRB array tools software. Class Comparison test between N/R and I areas was based on paired t-test where N/R and I were paired for each patient. The biological relevance of up- and down-regulated genes was analyses with Ingenuity Pathways Analysis (Ingenuity® Systems).

Results From among 47000 probes, 17500 were filtered out. Probes with a p-value below than 0.005 were chosen and classified as up- or down-regulated ones. By this way, 896 differentially expressed genes between N/R and I zones were identified. Among these, 576 genes were upregulated (I/NR >1.5) and 320 downregulated (I/NR <0.75). With Ingenuity Pathways Analysis, a significant number of the top ranking differentially expressed genes were identified as inflammatory, Wnt and angiogenic pathways. Interleukin (IL)-6 and -8, chemokines (CXCL1, CXCL2, CXCL5, CXCL6, CXCL16) and arachidonate 5-lipoxygenase (ALOX5) were identified as the most upregulated in I zones in the inflammatory pathway. Interestingly, the alarmin S100A9 was found strongly upregulated in this pathway. Wnt5A and LRP (Low density lipoprotein receptor-related protein) 5 were upregulated whereas FZD (Frizzled homolog) 2 and DKK (dickkopf homolog) 3 were downregulated in the Wnt signaling pathway. Finally, stanniocalcin (STC)-1, an intermediate in angiogenesis was identified as the most upregulated gene in I zones compared to N/R zones. This difference of expression was confirmed at the protein level.

Conclusions Using a unique culture system, this study is the first to identify different expression pattern between two areas of synovial membrane from the same OA patient. These differences concern several key pathways involved in OA pathogenesis, i.e. inflammation, Wnt and angiogenesis. This analysis also provided interesting information regarding new potent intermediates as S100A9 and STC-1. They could be potential targets for chondroitin sulfate, one of the most used molecules in the management of OA. New experiments are being perfomed at the moment to elucidate the potential effect of this molecule on these specific differentially expressed genes in the same culture system.

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.